Back to search results

Effectiveness of Oncology Navigation for Cancer Patients

This study is looking at how well different types of support, called "central oncology navigation," help people with cancer. It's comparing two approaches: one uses central oncology navigation alone, and the other adds a special helper called an "oncology research navigator (ORN)" to that support. The study aims to see if having an ORN makes a difference. We'll be looking at how many supportive services are offered and how many patients join the study over six months. To join, you need to be at least 18 years old and have a new appointment for genitourinary (cancers of the urinary and reproductive organs) or thoracic (chest) cancers. The study plans to enroll 686 participants.

Study design
This is an interventional study comparing two different behavioral support approaches for cancer patients. It plans to enroll 686 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary goals of the study are measured for up to 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06618274

Effectiveness of Central Oncology Navigation and the Use of an ORN

Recruiting
NAAges 18+InterventionalTreatment
UNC Lineberger Comprehensive Cancer Center
~686 participants
Updated 2026-01-28 on ClinicalTrials.gov
What's tested:Intervention of oncology research navigator embedded in central oncology navigationCentral oncology navigation (SOC)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cohort 1-supportive service offered
Measured over Up to 6 months
+1 more outcome measured

Conditions

Cancer
Malignant Tumor

Explore related trials

Breast CarcinomaMalignant Digestive System NeoplasmMalignant Genitourinary System NeoplasmMalignant neoplasm of lymphoid, hematopoietic and/or related tissueThoracic Neoplasm

Where it's being run

1 sites across 1 states
North Carolina1

Study leadership

  • William A Wood, MD · PRINCIPAL_INVESTIGATOR · UNC Lineberger Comprehensive Cancer Center

Who to contact

Mireille Leone
[email protected]
919-445-0768
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Informed consent obtained to participate in the study and HIPAA authorization for release of personal health information.
Subject is willing and able to comply with study activities based on the judgement of the investigator.
Age ≥ 18 years at the time of consent.
Subject has a new patient appointment for cancer care at a UNC Medical Center and a confirmed cancer diagnosis.

Exclusion

Lack of internet access.
Inability to understand the English language.
Psychological or other disability resulting in the inability to provide informed consent.

What this trial measures

  • Cohort 1-supportive service offeredUp to 6 months

    Participation in at least 1 supportive service offered will be measured by the number of patients receiving services. This information will be gathered from chart review.

  • Cohort 2: number of patients enrolledUp to 6 months

    Enrollment into non-treatment clinical studies will be measured by the number of patients enrolled at any time. This information will be gathered from chart review.